FDA Commissioner Questions COVID Booster Efficacy for Healthy Individuals

Shifting Science and Public Trust

• 🎯 Gold standard science and common sense are being re-emphasized regarding COVID-19 vaccines.
• ⚠️ Initial data suggested COVID vaccines reduced illness severity when the strain was a good match, but the situation has changed with a different virus and broad population immunity.
• ❓ The necessity of annual boosters, especially for children over their lifespan, remains an untested theory presented as dogma, leading to distrust in public health officials.

Need for New Clinical Trials

• 🔬 The FDA has requested vaccine makers conduct proper clinical trials to assess current efficacy, as it has been four to five years since the last trials.
• 💡 The goal is to gather hard, real data to inform decisions, rather than relying on established dogma.
• 📈 Results from rapid clinical trials are expected before May to determine if continued vaccination is necessary.

Vaccine Injury and Data Gaps

• ⚠️ The FDA does not currently have data to support the long-term benefit of COVID boosters for healthy individuals.
• 💬 There are hundreds of thousands of reported injuries from the vaccine, with some suspecting vaccine injury as a cause of long COVID.
• 🩺 The FDA is investigating cases of deaths in children following COVID vaccination, a process that was not initiated by the Biden administration.

Understanding Coronaviruses and Vaccines

• 🦠 Coronaviruses, like the common cold, are difficult to develop vaccines for, and historically, vaccines for such viruses have not been developed.
• 🚫 Early trials did not study silent infections or asymptomatic spread, leading to an incorrect assumption that vaccines would prevent infection entirely.
• ⚡ While it's potential to create a vaccine better than natural infection, it is very difficult to achieve.